Baebies Overview

  • Status
  • Private

  • Employees
  • 121

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $266K

  • Investors
  • 36

Baebies General Information

Description

Developer of screening and pediatric testing technology intended to save the lives of newborns. The company's technology operates on digital microfluidics which maximizes diagnostic yield from low-volume samples, one drop of blood is used to quantitatively measure the activity of lysosomal enzymes from newborn dried blood spot specimens, enabling physicians with early disease detection and multifunctional diagnostic testing for children and adults.

Contact Information

Website
www.baebies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 25 Alexandria Way
  • Durham, NC 27703
  • United States
+1 (919) 000-0000

Baebies Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baebies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
22. Grant 23-May-2022 $266K 000.00 Completed Generating Revenue
21. Later Stage VC 03-May-2022 000.00 000.00 Completed Generating Revenue
20. Grant 21-Sep-2021 00000 000.00 Completed Generating Revenue
19. Later Stage VC (Series B) 25-May-2021 000.00 000.00 Completed Generating Revenue
18. Grant 19-May-2021 00.00 00.00 Completed Generating Revenue
17. Grant 20-Apr-2021 000.00 00.00 Completed Generating Revenue
16. Grant 11-Feb-2021 000 00.00 Completed Generating Revenue
15. Grant 18-Jun-2020 000 00.00 Completed Generating Revenue
14. Debt - PPP 15-Apr-2020 $1.61M $9.4M Completed Generating Revenue
13. Grant 01-Mar-2020 $171K $9.4M Completed Generating Revenue
To view Baebies’s complete valuation and funding history, request access »

Baebies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00 00 00 000
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A 16,250,000 $0.000100 $0.8 $0.8 1x $0.8 32.5%
To view Baebies’s complete cap table history, request access »

Baebies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of screening and pediatric testing technology intended to save the lives of newborns. The company's technology
Diagnostic Equipment
Durham, NC
121 As of 2022
000.00
0000000000 000.00

000000

ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000 000000000
Brea, CA
00000 As of 0000
0.000 0000-00-00
000000&0

000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000000000 000000000
Waltham, MA
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Baebies Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Beckman Coulter Corporate Backed or Acquired Brea, CA 00000 000000&0
00000000000 Corporation Waltham, MA 00000 00000000
000000000000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
000000 000000000 Formerly VC-backed Abingdon, United Kingdom 000 00000 000000&0 00000
000000000 Venture Capital-Backed Newcastle Upon Tyne, United Kingdom 000 00000 0000000000 0 00000
You’re viewing 5 of 10 competitors. Get the full list »

Baebies Patents

Baebies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220220530-A1 Detection of glycosaminoglycans Pending 23-May-2019 00000000
US-11035855-B2 Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening Active 29-Apr-2016 000000000000
US-20210311042-A1 Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening Pending 29-Apr-2016 000000000000
AU-2017257183-A1 Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening Active 29-Apr-2016 000000000000
CA-3021348-A1 Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening Pending 29-Apr-2016 G01N33/54366
To view Baebies’s complete patent history, request access »

Baebies Executive Team (8)

Name Title Board Seat Contact Info
Richard West Ph.D Co-Founder, Chief Executive Officer & Board Member
Vamsee Pamula Ph.D Co-Founder, President & Board Member
Vijay Srinivasan Ph.D Vice President, Product Development
You’re viewing 3 of 8 executive team members. Get the full list »

Baebies Board Members (5)

Name Representing Role Since
Dennis Sacha Self Board Member 000 0000
Nicholas Naclerio Ph.D Illumina Ventures Board Member 000 0000
Richard West Ph.D Baebies Co-Founder, Chief Executive Officer & Board Member 000 0000
Vamsee Pamula Ph.D Baebies Co-Founder, President & Board Member 000 0000
William Hawkins III Self Board Member 000 0000
To view Baebies’s complete board members history, request access »

Baebies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baebies Investors (36)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aaron Biek Angel (individual) Minority 000 0000 000000 0
BOE Technology Group Corporation Minority 000 0000 000000 0
Brett Rule Angel (individual) Minority 000 0000 000000 0
Collective Capital Ventures Venture Capital Minority 000 0000 000000 0
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 36 investors. Get the full list »